Causal Inference for Genetically Determined Levels of High-Density Lipoprotein Cholesterol and Risk of Infectious Disease.


Journal

Arteriosclerosis, thrombosis, and vascular biology
ISSN: 1524-4636
Titre abrégé: Arterioscler Thromb Vasc Biol
Pays: United States
ID NLM: 9505803

Informations de publication

Date de publication:
01 2020
Historique:
pubmed: 7 11 2019
medline: 21 4 2020
entrez: 8 11 2019
Statut: ppublish

Résumé

HDL (high-density lipoprotein) cholesterol (HDL-C) and LDL (low-density lipoprotein) cholesterol (LDL-C) are inversely associated with infectious hospitalizations. Whether these represent causal relationships is unknown. Approach and Results: Adults of 40 to 69 years of age were recruited from across the United Kingdom between 2006 and 2010 and followed until March 31, 2016, as part of the UK Biobank. We determined HDL-C, LDL-C, and triglyceride polygenic scores for UK Biobank participants of British white ancestry (n=407 558). We examined the association of lipid levels and polygenic scores with infectious hospitalizations, antibiotic usage, and 28-day sepsis survival using Cox proportional hazards or logistic regression models. Measured levels of HDL-C and LDL-C were inversely associated with risk of infectious hospitalizations, while triglycerides displayed a positive association. A 1-mmol/L increase in genetically determined levels of HDL-C associated with a hazard ratio for infectious disease of 0.84 ([95% CI, 0.75-0.95]; Our results provide causal inference for an inverse relationship between HDL-C, but not LDL-C or triglycerides, and risk of an infectious hospitalization.

Identifiants

pubmed: 31694394
doi: 10.1161/ATVBAHA.119.313381
pmc: PMC6946100
doi:

Substances chimiques

Cholesterol, HDL 0

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

267-278

Subventions

Organisme : Medical Research Council
ID : MC_PC_17228
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_QA137853
Pays : United Kingdom
Organisme : CIHR
Pays : Canada

Commentaires et corrections

Type : CommentIn

Références

N Engl J Med. 2014 Jul 17;371(3):203-12
pubmed: 25014686
Am J Epidemiol. 2015 Feb 15;181(4):251-60
pubmed: 25632051
JAMA. 2017 Nov 21;318(19):1925-1926
pubmed: 29164242
Infect Immun. 2001 May;69(5):2821-8
pubmed: 11292694
Lancet. 2012 Aug 11;380(9841):572-80
pubmed: 22607825
Nat Genet. 2018 Sep;50(9):1219-1224
pubmed: 30104762
Diabetes. 2015 Sep;64(9):3328-33
pubmed: 25972569
J Crit Care. 2017 Apr;38:289-294
pubmed: 28013095
Semin Cell Dev Biol. 2007 Oct;18(5):616-26
pubmed: 17719248
Cell Metab. 2017 Jan 10;25(1):197-207
pubmed: 27866837
JAMA. 2016 Feb 23;315(8):801-10
pubmed: 26903338
Eur Heart J. 2017 Aug 21;38(32):2478-2486
pubmed: 28419274
N Engl J Med. 2012 Nov 29;367(22):2089-99
pubmed: 23126252
Proc Natl Acad Sci U S A. 1993 Dec 15;90(24):12040-4
pubmed: 8265667
JAMA Netw Open. 2019 Jan 4;2(1):e187223
pubmed: 30657536
Eur Heart J. 2016 Aug 1;37(29):2315-2381
pubmed: 27222591
N Engl J Med. 2017 May 18;376(20):1933-1942
pubmed: 28514624
N Engl J Med. 2007 Nov 22;357(21):2109-22
pubmed: 17984165
J Crit Care. 2014 Oct;29(5):723-7
pubmed: 24891152
J Crit Care. 2015 Jun;30(3):506-10
pubmed: 25702844
Nat Immunol. 2014 Feb;15(2):152-60
pubmed: 24317040
Infect Immun. 2005 Apr;73(4):2321-6
pubmed: 15784577
Stat Methods Med Res. 2017 Oct;26(5):2333-2355
pubmed: 26282889
Nat Genet. 2013 Nov;45(11):1274-1283
pubmed: 24097068
Am J Respir Crit Care Med. 2019 Apr 1;199(7):854-862
pubmed: 30321485
Nat Genet. 2017 Sep;49(9):1392-1397
pubmed: 28714974
J Immunol. 2011 Aug 15;187(4):1529-35
pubmed: 21810617
Can J Cardiol. 2016 Nov;32(11):1263-1282
pubmed: 27712954
Eur Heart J. 2016 Oct 14;37(39):2999-3058
pubmed: 27567407
Int J Epidemiol. 2017 Dec 1;46(6):1734-1739
pubmed: 28398548
J Exp Med. 1996 Nov 1;184(5):1601-8
pubmed: 8920850
Nature. 2018 Oct;562(7726):203-209
pubmed: 30305743
Stat Med. 2016 May 20;35(11):1880-906
pubmed: 26661904
Handb Exp Pharmacol. 2015;224:483-508
pubmed: 25522999
Am J Epidemiol. 2017 Nov 1;186(9):1026-1034
pubmed: 28641372
Sci Rep. 2018 Nov 13;8(1):16764
pubmed: 30425299
Eur Heart J. 2018 Apr 7;39(14):1181-1190
pubmed: 29228167
Nat Genet. 2006 Aug;38(8):904-9
pubmed: 16862161
FEBS Lett. 2008 Nov 12;582(27):3711-8
pubmed: 18930053
Arterioscler Thromb Vasc Biol. 2010 Jul;30(7):1430-8
pubmed: 20448206
J Lipid Res. 2018 Aug;59(8):1519-1528
pubmed: 29895699
Front Pharmacol. 2015 Oct 23;6:244
pubmed: 26557091
Arterioscler Thromb Vasc Biol. 2007 May;27(5):1153-8
pubmed: 17303780
Infect Immun. 2003 Jun;71(6):3280-4
pubmed: 12761109
Nat Genet. 2017 Dec;49(12):1722-1730
pubmed: 29083407
Nat Genet. 2018 Nov;50(11):1514-1523
pubmed: 30275531
Crit Care Med. 2019 Mar;47(3):463-466
pubmed: 30394916
N Engl J Med. 2017 Sep 28;377(13):1217-1227
pubmed: 28847206
Nat Rev Cardiol. 2017 Oct;14(10):577-590
pubmed: 28569269
Circulation. 2010 Nov 9;122(19):1919-27
pubmed: 20974999
J Clin Invest. 2007 Mar;117(3):746-56
pubmed: 17332893

Auteurs

Mark Trinder (M)

From the Centre for Heart Lung Innovation (M.T., K.R.W., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.
Department of Experimental Medicine Program (M.T., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.

Keith R Walley (KR)

From the Centre for Heart Lung Innovation (M.T., K.R.W., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.
Department of Medicine (K.R.W., J.H.B., L.R.B.) associated with the University of British Columbia, Vancouver, Canada.

John H Boyd (JH)

From the Centre for Heart Lung Innovation (M.T., K.R.W., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.
Department of Experimental Medicine Program (M.T., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.
Department of Medicine (K.R.W., J.H.B., L.R.B.) associated with the University of British Columbia, Vancouver, Canada.

Liam R Brunham (LR)

From the Centre for Heart Lung Innovation (M.T., K.R.W., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.
Department of Experimental Medicine Program (M.T., J.H.B., L.R.B.), associated with the University of British Columbia, Vancouver, Canada.
Department of Medicine (K.R.W., J.H.B., L.R.B.) associated with the University of British Columbia, Vancouver, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH